Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Neogi, Ujjwal ^a,b   Prarthana, Sreenivasa B ^a   D'Souza, George ^a   DeCosta, Ayesha ^a,b   Kuttiatt, Vijesh S ^a   Ranga, Udaykumar ^c   Shet, Anita ^a,b  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RECEPTOR;

ADULT; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDIA; MALE; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VIROGENESIS; VIRUS ISOLATION; VIRUS STRAIN;

EID: 77954686960     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-24     Document Type: Article

References (34)

1. Dalgleish A, Beverley P, Clapham P, Crawford D, Greaves M, Weiss R. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767. 10.1038/312763a0, 6096719.
2. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767-768. 10.1038/312767a0, 6083454.
3. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877. 10.1126/science.272.5263.872, 8629022.
4. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666. 10.1038/381661a0, 8649511.
5. Jensen M, 't Wout A. Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 2003, 5:104-112.
6. Skrabal K, Low AJ, Dong W, Sing T, Cheung PK, Mammano F, Harrigan PR. Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model. J Clin Microbiol 2007, 45:279-284. 10.1128/JCM.01118-06, 1829003, 17122004.
7. Poveda E, Briz V, Quinones-Mateu M, Soriano V. HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 2006, 20:1359-1367. 10.1097/01.aids.0000233569.74769.69, 16791010.
8. Raymond S, Delobel P, Mavigner M, Ferradini L, Cazabat M, Souyris C, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J. Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses. J Acquir Immune Defic Syndr 2010, 53:167-75. 10.1097/QAI.0b013e3181c8413b, 19996764.
9. Pillai S, Good B, Richman D, Corbeil J. A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses 2003, 19:145-149. 10.1089/088922203762688658, 12643277.
10. Sing T, Low AJ, Beerenwinkel N, Sander O, Cheung PK, Domingues FS, Büch J, Däumer M, Kaiser R, Lengauer T, Harrigan PR. Predicting HIV co-receptor usage based on genetic and clinical covariates. Antivir Ther 2007, 12:1097-1106.
11. Boisvert S, Marchand M, Laviolette F, Corbeil J. HIV-1 coreceptor usage prediction without multiple alignments: an application of string kernels. Retrovirology 2008, 5:110. 10.1186/1742-4690-5-110, 2637298, 19055831.
12. Jensen MA, Coetzer M, van 't Wout AB, Morris L, Mullins JI. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on Envelope V3 sequences. J Virol 2006, 80:4698-4704. 10.1128/JVI.80.10.4698-4704.2006, 1472078, 16641263.
13. Geography Search Interface, Los Alamos database. , http://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.comp
14. Papathanasopoulos MA, Cilliers T, Morris L, Mokili JL, Dowling W, Birx DL, McCutchan FE. Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. AIDS Res Hum Retroviruses 2002, 18:879-886. 10.1089/08892220260190362, 12201911.
15. Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, Pollakis G, Schuitemaker H, Fontanet AL, Rinke de Wit TF. HIV-1 subtype C syncytium- and non-syncytiuminducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999, 13:1305-1311. 10.1097/00002030-199907300-00006, 10449282.
16. van Rensburg EJ, Smith TL, Zeier M, Robson B, Sampson C, Treurnicht F, Engelbrecht S. Change in co-receptor usage of current South African HIV-1 subtype C primary isolates. AIDS 2002, 16:2479-2480. 10.1097/00002030-200212060-00015, 12461424.
17. Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000, 271:253-258. 10.1006/viro.2000.0297, 10860879.
18. Sundaravaradan V, Das SR, Ramakrishnan R, Sehgal S, Gopalan S, Ahmad N, Jameel S. Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, co-receptor utilization and replication efficiency in primary T-lymphocytes and monocyte derived macrophages. Virol J 2007, 4:126. 10.1186/1743-422X-4-126, 2216014, 18036244.
19. Kandathil AJ, Kannangai R, Abraham OC, Pulimood SA, Jensen MA, Sridharan G. HIV-1 with Predicted CXCR4 Genotype Identified in Clade C from India. Mol Diag Ther 2009, 13:19-24.
20. Neogi U, Sood V, Chowdhury A, Das S, Ramachandran VG, Sreedhar VK, Wanchu A, Ghosh N, Banerjea AC. Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage. AIDS Res Ther 2009, 6:28. 10.1186/1742-6405-6-28, 2794860, 19954551.
21. Dash PK, Siddappa NB, Mangaiarkarasi A, Mahendarkar AV, Roshan P, Anand KK, Mahadevan A, Satishchandra P, Shankar SK, Prasad VR, Ranga U. Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection. Retrovirology 2008, 5:25. 10.1186/1742-4690-5-25, 2292743, 18328091.
22. Bachmann MH, Delwart EL, Shpaer EG, Lingenfelter P, Singal R, Mullins JI. WHO Network on HIV Isolation and Characterization. Rapid genetic characterization of HIV-1 from four WHO-sponsored vaccine evaluation sites using a heteroduplex mobility assay. AIDS Res Hum Retroviruses 1994, 10:1343-1351.
23. Gharu L, Ringe R, Pandey S, Paranjape R, Bhattacharya J. HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded co-receptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop. Virus Res 2009, 144:306-314. 10.1016/j.virusres.2009.04.020, 19409946.
24. REGA subtyping tools v2.0. , http://www.bioafrica.net/rega-genotype/html/subtypinghiv.html
25. NCBI Viral Genotyping tools. , http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi
26. Recombination Identification Program (RIP 3.0). , http://www.hiv.lanl.gov/content/sequence/RIP/RIP.html
27. Regoes RR, Bonhoeffer S. The HIV co-receptor switch: a population dynamical perspective. Trends Microbiol 2005, 13:269-77. 10.1016/j.tim.2005.04.005, 15936659.
28. Coetzer M, Nedellec R, Salkowitz J, McLaughlin S, Liu Y, Heath L, Mullins JI, Mosier DE. Evolution of CCR5 use before and during co-receptor switching. J Virol 2008, 82:11758-66. 10.1128/JVI.01141-08, 2583682, 18815295.
29. Ramalingam S, Kannangai R, Vijayakumar TS, Subramanian S, Abraham OC, Rupali P, Jesudason MV, Sridharan G. Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with the low frequency of X4 phenotype of HIV-1 in India. Indian J Med Res 2002, 116:90-95.
30. Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun TW, Fauci AS. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998, 161:3195-3201.
31. de Roda Husman AM, Blaak H, Brouwer M, Schuitemaker H. CC Chemokine Receptor 5 Cell-Surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. J Immunol 1999, 163:4597-4603.
32. Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F. Changes in CCR5 and CXCR4 expression and [beta]-Chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy. JAIDS 2002, 29:122-131.
33. Castonguay L, Wengg Y, Adolfsen W, Di Salvo J, Kilburn R, Caldwell C, Daugherty BL, Finke PE, Hale JJ, Lynch CL, Mills SG, MacCoss M, Springer MS, Julie A. Binding of 2-aryl-4(piperidin-1yl)butanmines and 1, 3, 4-trisubstitued pyrrolidines to human CCR5: a molecular modelling-guide mutagenesis study of the binding pocket. Biochemistry 2003, 42:1544-1550. 10.1021/bi026639s, 12578367.
34. Soriano V, Clo-Federico P, Kaiser R, Calvez V, Gatell JM, di Perri G, Pillay D, Rockstroh J, Geretti AM. When and how to use maraviroc in HIV-infected patients. AIDS 2009, 23:2377-2385. 10.1097/QAD.0b013e328332d32d, 19834318.